Answers are grounded in this paper and cite their sources.
This pilot study compared military service member’s preference between the modified ProSomnus IA TM and TAP 3 TM appliances for the treatment of obstructive sleep apnea (OSA) and sleep bruxism. Thirteen patients diagnosed with OSA and bruxism were referred for fabrication of a mandibular advancement device (MAD). Using a random allocation process, patients were treated for one month with either the modified ProSomnus IA TM or the TAP 3 TM MAD. After one month, the patients received the other appliance. By the end of the study, all patients were treated with both devices for a one-month period. During the final appointment, the patients were asked which device was preferred for long-term treatment of OSA and sleep bruxism. Eight of 13 patients enrolled in this study preferred the modified ProSomnus IA TM over the TAP 3 TM MAD for the treatment of OSA. One patient was unable to tolerate either device; two dropped out of the study. The two patients who preferred the TAP 3 TM also used a CPAP simultaneously. The modified ProSomnus IA TM was the preferreddevice for most patients with OSA and sleep bruxism. Patients who used a CPAP with the MAD preferred the TAP 3 TM over the modified ProSomnus IA TM during the 2-month study period.
No takes yet. Share an insight, caveat, or question.
Ryser et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: